Dual Face of Vγ9Vδ2-T Cells in Tumor Immunology: Anti-versus Pro-Tumoral Activities

被引:50
作者
Xiang, Zheng [1 ]
Tu, Wenwei [1 ]
机构
[1] Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Lab Translat Immunol, Hong Kong, Hong Kong, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2017年 / 8卷
关键词
V gamma 9V delta 2-T cells; antitumor activity; pro-tumor activity; tumor immunity; tumor immunotherapy; DELTA-T-CELLS; TCR-GAMMA-DELTA; PRENYL PYROPHOSPHATE ANTIGENS; BREAST-CANCER PATIENTS; EPSTEIN-BARR-VIRUS; PERIPHERAL-BLOOD; ADOPTIVE IMMUNOTHERAPY; IMMUNE-RESPONSES; ZOLEDRONIC ACID; DENDRITIC-CELLS;
D O I
10.3389/fimmu.2017.01041
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
V gamma 9V delta 2-T cells are considered as potent effector cells for tumor immunotherapy through directly killing tumor cells and indirectly regulating other innate and adaptive immune cells to establish antitumoral immunity. The antitumoral activity of V gamma 9V delta 2-T cells is governed by a complicated set of activating and inhibitory cell receptors. In addition, cytokine milieu in tumor microenvironment can also induce the pro-tumoral activities and functional plasticity of V gamma 9V delta 2-T cells. Here, we review the anti-versus pro-tumoral activities of V gamma 9V delta 2-T cells and discuss the mechanisms underlying the recognition, activation, differentiation and regulation of V gamma 9V delta 2-T cells in tumor immunosurveillance. The comprehensive understanding of the dual face of V gamma 9V delta 2-T cells in tumor immunology may improve the therapeutic efficacy and clinical outcomes of V gamma 9V delta 2-T cell-based tumor immunotherapy.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] A regulatory cross-talk between Vγ9Vδ2 T lymphocytes and mesenchymal stem cells
    Martinet, Ludovic
    Fleury-Cappellesso, Sandrine
    Gadelorge, Melanie
    Dietrich, Gilles
    Bourin, Philippe
    Fournie, Jean-Jacques
    Poupot, Remy
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (03) : 752 - 762
  • [32] Preferential Th1 Cytokine Profile of Phosphoantigen-Stimulated Human Vγ9Vδ2T Cells
    Dunne, Margaret R.
    Mangan, Bozgana A.
    Madrigal-Estebas, Laura
    Doherty, Derek G.
    MEDIATORS OF INFLAMMATION, 2010, 2010
  • [33] Potent antitumor activity of zoledronic acid-induced Vγ9Vδ2 T cells against primary effusion lymphoma
    Goto, Hirold
    Matsuda, Kould
    Srikoon, Pattaravadee
    Kariya, Ryusho
    Hattori, Shinichiro
    Taura, Manabu
    Katano, Harutaka
    Okada, Seiji
    CANCER LETTERS, 2013, 331 (02) : 174 - 182
  • [34] Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells
    Boutin, Lola
    Scotet, Emmanuel
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [35] Directing the migration of serum-free, ex vivo-expanded Vγ9Vδ2 T cells
    Parwani, Kiran K.
    Branella, Gianna M.
    Burnham, Rebecca E.
    Burnham, Andre J.
    Bustamante, Austre Y. Schiaffino
    Foppiani, Elisabetta Manuela
    Knight, Kristopher A.
    Petrich, Brian G.
    Horwitz, Edwin M.
    Doering, Christopher B.
    Spencer, H. Trent
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [36] Aminobisphosphonate-pretreated dendritic cells trigger successful Vγ9Vδ2 T cell amplification for immunotherapy in advanced cancer patients
    Cabillic, Florian
    Toutirais, Olivier
    Lavoue, Vincent
    de La Pintiere, Cecile Thomas
    Daniel, Pascale
    Rioux-Leclerc, Nathalie
    Turlin, Bruno
    Monkkonen, Hannu
    Monkkonen, Jukka
    Boudjema, Karim
    Catros, Veronique
    Bouet-Toussaint, Francoise
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (11) : 1611 - 1619
  • [37] A CD123-specific chimeric antigen receptor augments anti-acute myeloid leukemia activity of Vγ9Vδ2 T cells
    Zhang, Xi
    Ang, Wei Xia
    Du, Zhicheng
    Ng, Yu Yang
    Zha, Shijun
    Chen, Can
    Xiao, Lin
    Ng, Jia Yi
    Chng, Wee Joo
    Wang, Shu
    IMMUNOTHERAPY, 2022, 14 (05) : 321 - 336
  • [38] Vγ9Vδ2 T Cells in the Bone Marrow of Myeloma Patients: A Paradigm of Microenvironment-Induced Immune Suppression
    Castella, Barbara
    Foglietta, Myriam
    Riganti, Chiara
    Massaia, Massimo
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [39] BTN3A Targeting Vγ9Vδ2 T Cells Antimicrobial Activity Against Coxiella burnetii-Infected Cells
    Gay, Laetitia
    Mezouar, Soraya
    Cano, Carla
    Foucher, Etienne
    Gabriac, Melanie
    Fullana, Marie
    Madakamutil, Loui
    Mege, Jean-Louis
    Olive, Daniel
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [40] A Bispecific Single-Domain Antibody Boosts Autologous Vγ9Vδ2-T Cell Responses Toward CD1d in Chronic Lymphocytic Leukemia
    de Weerdt, Iris
    Lameris, Roeland
    Ruben, Jurjen M.
    de Boer, Renate
    Kloosterman, Jan
    King, Lisa A.
    Levin, Mark-David
    Parren, Paul W. H., I
    de Gruijl, Tanja D.
    Kater, Arnon P.
    van der Vliet, Hans J.
    CLINICAL CANCER RESEARCH, 2021, 27 (06) : 1744 - 1755